Sunshine Biopharma director Andrew Keller declines to seek board reelectionPUBT·Aug 28 at 08:06 PMSBFMW0.00%SBFM+2.70%
Sunshine Biopharma says K1.1 mRNA shows tumor suppression in liver cancer mouse modelsPUBT·Aug 26 at 01:01 PMSBFMW0.00%SBFM+2.70%
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancerbenzinga_article·Aug 26 at 12:31 PMSBFM+2.70%SBFMW0.00%
Sunshine Biopharma wins Canadian approval for generic Enalapril tabletsPUBT·Aug 19 at 01:38 PMSBFMW0.00%SBFM+2.70%
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drugbenzinga_article·Aug 19 at 12:30 PMSBFM+2.70%
Sunshine Biopharma Q2 net loss narrows 11.67% to $1.56 million; revenue slips 1.6% to $9.26 millionPUBT·Aug 13 at 08:15 PMSBFM+2.70%SBFMW0.00%
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market | SBFM Stock NewsStockTitan·Aug 7 at 05:00 AMSBFMW0.00%SBFM+2.70%
Sunshine Biopharma wins Canadian approval for generic Dienogest tabletsPUBT·Aug 4 at 01:23 PMSBFMW0.00%SBFM+2.70%
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approvalbenzinga_article·Aug 4 at 12:31 PMSBFMW0.00%SBFM+2.70%
Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22PUBT·Aug 3 at 12:52 PMSBFMW0.00%SBFM+2.70%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·Jul 20 at 09:05 PMMBAI0.00%CPHI-2.37%
Sunshine Biopharma plans up to $4 million at-the-market share sale via Aegis CapitalPUBT·Jul 20 at 08:28 PMSBFMW0.00%SBFM+2.70%
